Monica Fernandez-Martinez

Vigo, GA 36213, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis.

Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis.

Journal: Science (New York, N.Y.)
Published: February 26, 2026

Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models.

Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 26, 2025

Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors.

Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors.

Journal: Journal of translational medicine
Published: October 28, 2024

Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma.

Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma.

Journal: Molecular oncology
Published: September 27, 2024

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients.

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients.

Journal: Scientific reports
Published: September 10, 2024

Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.

Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.

Journal: Cancer medicine
Published: June 27, 2022

Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.

Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.

Journal: Cancers
Published: April 29, 2022

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

Journal: European urology
Published: February 21, 2022

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

Journal: Nature communications
Published: April 08, 2021

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers.

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers.

Journal: Clinical & experimental metastasis
Published: October 22, 2020

Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies.

Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies.

Journal: Frontiers in oncology
Published: January 06, 2020

CTCs Expression Profiling for Advanced Breast Cancer Monitoring.

CTCs Expression Profiling for Advanced Breast Cancer Monitoring.

Journal: Cancers
Published: October 24, 2019
Showing 1-12 of 34

Last Updated: 09/26/2026